LncRNAs in pancreatic cancer

Xiaoyi Huang; Xiaosong Zhi; Yisha Gao; Na Ta; Hui Jiang; Jianming Zheng

doi:10.18632/oncotarget.10545

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

LncRNAs in pancreatic cancer

Xiaoyi Huang, Xiaosong Zhi, Yisha Gao, Na Ta, Hui Jiang and Jianming Zheng _

PDF | HTML | How to cite

Oncotarget. 2016; 7:57379-57390. https://doi.org/10.18632/oncotarget.10545

Metrics: PDF 3844 views | HTML 5180 views | ?

Abstract

Xiaoyi Huang1,*, Xiaosong Zhi2,*, Yisha Gao1, Na Ta1, Hui Jiang1 and Jianming Zheng1

1 Department of Pathology, Changhai Hospital, Second Military Medical University, Shanghai, China

2 Department of Cell Biology, Second Military Medical University, Shanghai, China

* These authors have contributed equally to this work

Correspondence to:

Jianming Zheng, email:

Hui Jiang, email:

Keywords: pancreatic cancer; lncRNA; pathogen; mechanism; clinical

Received: March 23, 2016 Accepted: June 17, 2016 Published: July 12, 2016

Abstract

Pancreatic cancer (PC) is one of the most common causes of cancer-related death. The underlying mechanism of PC is not completely understood at present. Studies in recent years have demonstrated that long non-coding RNAs (lncRNAs) have multiple biological functions in cell growth, differentiation and proliferation. Notably, expressions of some lncRNAs undergo significant changes in the initiation and progression of cancers. In addition, lncRNAs are reported to be involved in various steps of PC development and have a potential value in the diagnosis, treatment and prognostic prediction of PC. In this review, we highlight recent evidence related to the molecular mechanism of lncRNAs in growth, survival, invasion, metastasis, angiogenesis and apoptosis of PC cells, and discuss the potential clinical application of lncRNAs to the diagnosis, treatment and prognostic prediction of PC.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 10545

Publication Alerts

Reviews:

LncRNAs in pancreatic cancer

Abstract